Camel milk-derived small molecule peptide and its application

The preparation of small molecule peptide Pro-Phe-Pro-Met-Trp-Thr-Phe-Leu-Ser-Arg by fermenting camel milk solves the side effect problem of chemically synthesized DPP-IV inhibitors, achieving highly efficient inhibition of dipeptidyl peptidase IV activity and improvement of diabetic cell function, and is suitable for functional foods and health products.

CN116284234BActive Publication Date: 2024-11-08KUNMING UNIV OF SCI & TECH
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202310089954.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-02-09
Publication Date
2024-11-08
Estimated Expiration
2043-02-09

AI Technical Summary

Technical Problem

Existing chemically synthesized DPP-IV inhibitors have side effects when used to treat type 2 diabetes, and the development of food-derived DPP-IV inhibitors has not fully utilized the potential of dairy-derived substances.

Method used

The small molecule peptide Pro-Phe-Pro-Met-Trp-Thr-Phe-Leu-Ser-Arg was prepared by fermenting camel milk and used to prepare dipeptidyl peptidase IV inhibitors. The peptide sequence with high inhibitory activity was obtained through multi-step purification and identification, and a suitable dosage form was prepared.

Benefits of technology

Small molecule peptides significantly inhibit dipeptidyl peptidase IV activity and improve high glucose-induced insulin resistance in Hepg2 cells, providing a safe and effective hypoglycemic mechanism, suitable for the preparation of functional foods and health products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The invention discloses a camel milk-derived small molecule peptide, wherein the amino acid sequence of the small molecule peptide is Pro‑Phe‑Pro‑Met‑Trp‑Thr‑Phe‑Leu‑Ser‑Arg, and the molecular weight is 1281.64Da; the small molecule peptide of the invention is applied to the preparation of a dipeptidyl peptidase IV inhibitor, and the results show that the small molecule peptide has dipeptidyl peptidase IV inhibitory activity, the inhibition rate of the dipeptidyl peptidase IV is 76%, and the half inhibition concentration (IC 50 ) is 0.732 mg / mL; the small molecule peptide of the present invention is used to prepare functional foods, health products and drugs for the treatment or auxiliary treatment of type 2 diabetes, and the preparation is simple, and it is suitable for industrial production and market promotion.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Gly-Pro-type peptide with DPP-IV inhibitory activity and application thereof

    CN114349819A

  • Tartary buckwheat active peptide as well as preparation method and new application thereof

    CN115010787A

  • Protein Hydrolysate Enriched In Peptides Inhibiting DPP-IV And Their Use

    US20090075904A1